Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Dec 19, 2021 10:13pm
258 Views
Post# 34245674

NSX001 Buy my shares for a 1.00

NSX001 Buy my shares for a 1.00 I am not sure how much plainer I can say it, how can that happen if I had none to sell  ? Bonehead ! Sorry but I can not cheer for a CEO that takes a company from 1.50 a share on promises of revenue for the last four years from all these products he has given away for nothing because Tetra was broke and will be broke again soon to .135 cents and has lined his pockets along the way. Where the CFO leaves, where the president is gone and they have a deficit of 100,000,000 dollars with undisclosed deal amounts all over, no lab , no realestate,borrowing a medical device from Canopy for the qixleef trials, not selling one drug and calling themselves leaders , no one even knows where the office in Ontario is , Guy is not a Medical Doctor and he has no sense of reality, big Pharma is sitting back laughing at his dog and pony show otherwise the price would not be at .135 
Teva and Tilray are working on bringing Syqe to market , it has Health Canada approval and is the similar to Qixleef and the mighty medic that Tetra is spending millions on .The Syqe inhaler makes the Tetra contraption look like some military device. Tetra is no threat or interest to any of these big Pharma companies.Teva is a 10 billion dollar company, has 500 drugs, labs, real estate , warehouses all over the world it trades 8.20 cents , that is 200 times the size of Tetra that would put Tetra at .05 cents at best , thats reality.I was just too smart too late so loosing the last 20% doesn't matter to me.Show us where the money is going Guy ? and where it has gone 100,000,000 and nothing to show for it .
<< Previous
Bullboard Posts
Next >>